Department of Gastroenterology and Hepatology, University Clinical Center Tuzla, Tuzla 75000, Tuzlanski Kanton, Bosnia and Herzegovina.
Department of Nephrology, Dialysis and Transplantation, University Clinical Center Tuzla, Tuzla 75000, Tuzlanski Kanton, Bosnia and Herzegovina.
World J Gastroenterol. 2021 May 28;27(20):2630-2642. doi: 10.3748/wjg.v27.i20.2630.
The incidence and prevalence of inflammatory bowel disease (IBD) vary between regions but have risen globally in recent decades. A lack of data from developing nations limits the understanding of IBD epidemiology.
To perform a follow-up review of IBD epidemiology in the Tuzla Canton of Bosnia-Herzegovina during a 10-year period (2009-2019).
We prospectively evaluated the hospital records of both IBD inpatients and outpatients residing in Tuzla Canton for the specified period of time between January 1, 2009 and December 31, 2019. Since all our patients had undergone proximal and distal endoscopic evaluations at the hospital endoscopy unit, we used the hospital's database as a primary data source, alongside an additional cross-relational search of the database. Both adult and pediatric patients were included in the study. Patients were grouped by IBD type, phenotype, age, and gender. Incidence rates were calculated with age standardization using the European standard population. Trends in incidence and prevalence were evaluated as a 3-year moving average and average annual percentage change rates.
During the 10-year follow-up period, 651 patients diagnosed with IBD were monitored (of whom 334, or 51.3%, were males, and 317, or 48.7%, were females). Of all the patients, 346 (53.1%) had been diagnosed with ulcerative colitis (UC), 292 (44.9%) with Crohn's disease (CD), and 13 (2%) with indeterminate colitis (IC). We observed 440 newly diagnosed patients with IBD: 240 (54.5%) with UC, 190 (43.2%) with CD, and 10 (2.3%) with IC. The mean annual crude incidence rates were found to be 9.01/100000 population for IBD [95% confidence interval (CI): 8.17-9.85], with 4.91/100000 (95%CI: 4.29-5.54) for UC and 3.89/100000 (95%CI: 3.34-4.44) for CD. Calculated IBD prevalence in 2019 was 146.64/100000 (95%CI: 128.09-165.19), with 77.94/100000 (95%CI: 68.08-87.70) for UC and 65.77/100000 (95%CI: 54.45-74.1) for CD. The average annual IBD percentage change was 0.79% (95%CI: 0.60-0.88), with -2.82% (95%CI: -2.67 to -2.97) for UC and 6.92% (95%CI: 6.64-7.20) for CD. During the study period, 24,509 distal endoscopic procedures were performed. The incidence of IBD was 3.16/100 examinations (95%CI: 2.86-3.45) or 1.72/100 examinations (95%CI: 1.5-1.94) for UC and 1.36/100 examinations (95%CI: 1.17-1.56) for CD.
Trends in the incidence and prevalence of IBD in Tuzla Canton are similar to Eastern European averages, although there are significant epidemiological differences within geographically close and demographically similar areas.
炎症性肠病(IBD)的发病率和患病率在不同地区有所差异,但在过去几十年中在全球范围内呈上升趋势。发展中国家的数据匮乏限制了对 IBD 流行病学的理解。
对波斯尼亚和黑塞哥维那图兹拉州 10 年间(2009-2019 年)IBD 的流行病学进行随访回顾。
我们前瞻性评估了 2009 年 1 月 1 日至 2019 年 12 月 31 日期间居住在图兹拉州的 IBD 住院和门诊患者的医院记录。由于我们所有的患者都在医院内镜检查中心进行了近端和远端内镜评估,因此我们将医院的数据库作为主要数据源,并对数据库进行额外的交叉关联搜索。本研究纳入了成人和儿科患者。患者按 IBD 类型、表型、年龄和性别进行分组。使用欧洲标准人口进行年龄标准化后计算发病率。通过 3 年移动平均和平均年百分比变化率评估发病率和患病率的趋势。
在 10 年的随访期间,监测了 651 例确诊为 IBD 的患者(其中 334 例,即 51.3%为男性,317 例,即 48.7%为女性)。所有患者中,346 例(53.1%)被诊断为溃疡性结肠炎(UC),292 例(44.9%)被诊断为克罗恩病(CD),13 例(2%)被诊断为不确定结肠炎(IC)。我们观察到 440 例新诊断为 IBD 的患者:240 例(54.5%)为 UC,190 例(43.2%)为 CD,10 例(2.3%)为 IC。IBD 的年粗发病率估计为 9.01/100000 人,95%置信区间(CI)为 8.17-9.85,UC 的发病率为 4.91/100000 人,95%CI 为 4.29-5.54,CD 的发病率为 3.89/100000 人,95%CI 为 3.34-4.44。2019 年 IBD 的患病率估计为 146.64/100000 人,95%CI 为 128.09-165.19,UC 的患病率为 77.94/100000 人,95%CI 为 68.08-87.70,CD 的患病率为 65.77/100000 人,95%CI 为 54.45-74.1。IBD 的年平均百分比变化率为 0.79%,95%CI 为 0.60-0.88,UC 的变化率为-2.82%,95%CI 为-2.67 至-2.97,CD 的变化率为 6.92%,95%CI 为 6.64-7.20。在此期间,共进行了 24509 次远端内镜检查。IBD 的发病率为 3.16/100 次检查(95%CI:2.86-3.45)或 UC 的发病率为 1.72/100 次检查(95%CI:1.5-1.94),CD 的发病率为 1.36/100 次检查(95%CI:1.17-1.56)。
图兹拉州 IBD 的发病率和患病率趋势与东欧平均水平相似,但在地理位置相近且人口统计学相似的地区存在显著的流行病学差异。